These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

87 related articles for article (PubMed ID: 95450)

  • 41. Poly I-Mercapto Poly C: antiviral, anticellular, and pharmacologic effects.
    Vastola KA; Ho YK; Bardos TJ; Grossmayer BJ; Fruck-Diviak L; O'Malley JA
    Res Commun Chem Pathol Pharmacol; 1984 Sep; 45(3):407-19. PubMed ID: 6438740
    [TBL] [Abstract][Full Text] [Related]  

  • 42. [Levamisole, a chemically defined substance with immunostimulating potential--a review].
    Staber GF
    Fortschr Med; 1976 May; 94(14):793-800. PubMed ID: 5347
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Bovine interferon: its biology and application in veterinary medicine.
    Ohmann HB; Lawman MJ; Babiuk LA
    Antiviral Res; 1987 May; 7(4):187-210. PubMed ID: 2441661
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Immunosuppression, interferon, and viral infections.
    Glasgow LA
    Fed Proc; 1971; 30(6):1846-51. PubMed ID: 5001451
    [No Abstract]   [Full Text] [Related]  

  • 45. [Pathways of the pharmacological regulation of immunoreceptor function].
    Seĭfulla RD; Kim EK; Sentsova TB
    Farmakol Toksikol; 1979; 42(6):581-91. PubMed ID: 387439
    [No Abstract]   [Full Text] [Related]  

  • 46. [The immune regulatory function of interferon].
    Heron I; Berg K
    Ugeskr Laeger; 1978 Dec; 140(51):3210-1. PubMed ID: 726137
    [No Abstract]   [Full Text] [Related]  

  • 47. [Effect of interferon on the immune response of mice to immunization with the cells of transplantable leukemias and sarkomas].
    Skurkovich SV; Ol'shanskaia NV; Kalinina IA; Klinova EG; Eremkina EI
    Vopr Onkol; 1977; 23(9):44-50. PubMed ID: 910422
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Effect of interferon on thoracic duct lymphocyte output: induction with either poly I:poly C or vaccinia virus.
    Korngold R; Blank KJ; Murasko DM
    J Immunol; 1983 May; 130(5):2236-40. PubMed ID: 6187846
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Effect of mouse interferon and polyriboinosinic acid-polyribocytidylic acid on L-cell tumor growth in nude mice.
    Clercq ED
    Cancer Res; 1977 May; 37(5):1502-6. PubMed ID: 856466
    [TBL] [Abstract][Full Text] [Related]  

  • 50. The effects of proteolysis on the human immune mechanism in cancer. A preliminary communication.
    Thornes RD; Smyth H; Browne O; O'Gorman M; Reen DJ; Farrell D; Holland PD
    J Med; 1974; 5(1):92-7. PubMed ID: 4275505
    [No Abstract]   [Full Text] [Related]  

  • 51. [What is immunopharmacology?].
    Resch K
    Dtsch Med Wochenschr; 1983 Feb; 108(5):163-6. PubMed ID: 6600679
    [No Abstract]   [Full Text] [Related]  

  • 52. Immune interferon: some properties and functions.
    Baron S; Blalock JE; Dianzani F; Fleischmann WR; Georgiades JA; Johnson HM; Stanton GJ
    Ann N Y Acad Sci; 1980; 350():130-44. PubMed ID: 6165268
    [No Abstract]   [Full Text] [Related]  

  • 53. Sequential suppression by actinomycin D of interferon production and cellular resistance induced by Poly I:C.
    Vilcek J; Varacalli F
    J Gen Virol; 1971 Oct; 13(1):185-8. PubMed ID: 4331811
    [No Abstract]   [Full Text] [Related]  

  • 54. The rainbow trout (Oncorhynchus mykiss) interferon response in the ovary.
    Chaves-Pozo E; Zou J; Secombes CJ; Cuesta A; Tafalla C
    Mol Immunol; 2010 May; 47(9):1757-64. PubMed ID: 20356627
    [TBL] [Abstract][Full Text] [Related]  

  • 55. [Artificial interferon inducers].
    Bektemirov TA; Bektemirova MS
    Vopr Virusol; 1973; 18(2):131-42. PubMed ID: 4576998
    [No Abstract]   [Full Text] [Related]  

  • 56. Advances in interferon research - Medical Staff Conference.
    Creasey AA; Merigan TC
    West J Med; 1982 Mar; 136(3):227-35. PubMed ID: 6178224
    [No Abstract]   [Full Text] [Related]  

  • 57. Current view on the perspectives of interferon therapy.
    Borecký L
    Acta Virol; 1986 Mar; 30(2):161-9. PubMed ID: 2425613
    [TBL] [Abstract][Full Text] [Related]  

  • 58. [Theoretical and practical aspects of the problems of interferon].
    Povolotskiĭ IaL
    Zh Ushn Nos Gorl Bolezn; 1976; (2):111-6. PubMed ID: 773030
    [No Abstract]   [Full Text] [Related]  

  • 59. Interferon: its inducers and some aspects of host resistance in malignancy.
    Merigan TC
    Cancer Chemother Rep; 1974; 58(4):571-8. PubMed ID: 4604626
    [No Abstract]   [Full Text] [Related]  

  • 60. Augmentation of mouse natural killer cell activity by interferon and interferon inducers.
    Djeu JY; Heinbaugh JA; Holden HT; Herberman RB
    J Immunol; 1979 Jan; 122(1):175-81. PubMed ID: 310826
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.